Literature DB >> 1588937

Atherosclerosis: the eicosanoid connection.

A N Makheja1.   

Abstract

This bird's eye view presents connections between the metabolically short-lived local hormones (collectively known as eicosanoids) and atherosclerotic cardiovascular disease. The discussion will be centered around an overview of coronary atherosclerosis with an emphasis on the sequences involved in the formation of atherosclerotic lesions; structure and historical background of oxygenated fatty acids cyclooxygenase and lipoxygenase products--eicosanoids; the generation of free radicals during the formation of endoperoxides by cyclooxygenase; the involvement of eicosanoids in the atherosclerotic inflammatory process, and finally, the effects of non-steroidal and steroidal anti-inflammatory drugs on the synthesis of eicosanoids and experimental atherosclerosis. Little is known about the exact role of eicosanoids in the genesis of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1588937     DOI: 10.1007/bf00229585

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  32 in total

1.  THE ENZYMATIC FORMATION OF PROSTAGLANDIN E2 FROM ARACHIDONIC ACID PROSTAGLANDINS AND RELATED FACTORS 32.

Authors:  S BERGSTROEM; H DANIELSSON; B SAMUELSSON
Journal:  Biochim Biophys Acta       Date:  1964-07-15

2.  Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.

Authors:  M T Quinn; S Parthasarathy; L G Fong; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

3.  Anti-inflammatory drugs in experimental atherosclerosis. I. Relative potencies for inhibiting plaque formation.

Authors:  J M Bailey; J Butler
Journal:  Atherosclerosis       Date:  1973 May-Jun       Impact factor: 5.162

4.  Corticosteroids suppress cyclooxygenase messenger RNA levels and prostanoid synthesis in cultured vascular cells.

Authors:  J M Bailey; A N Makheja; J Pash; M Verma
Journal:  Biochem Biophys Res Commun       Date:  1988-12-30       Impact factor: 3.575

Review 5.  Suppression of principal atherosclerotic mechanisms by prostacyclins and other eicosanoids.

Authors:  A L Willis; D L Smith; C Vigo
Journal:  Prog Lipid Res       Date:  1986       Impact factor: 16.195

Review 6.  Pathogenesis and management of lipoprotein disorders.

Authors:  E J Schaefer; R I Levy
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245

7.  Short-term therapy of atherosclerosis with low dose indomethacin: an experimental study.

Authors:  V Dhawan; N K Ganguly; S Majumdar; R N Chakravarti
Journal:  J Med Primatol       Date:  1990       Impact factor: 0.667

8.  Acetylation of the NH2-terminal serine of prostaglandin synthetase by aspirin.

Authors:  G J Roth; C J Siok
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

Review 9.  Is atherosclerosis a complication of long-term corticosteroid treatment?

Authors:  D J Nashel
Journal:  Am J Med       Date:  1986-05       Impact factor: 4.965

10.  Inflammatory responses in cuff-induced atherosclerosis in rabbits.

Authors:  J Hirosumi; A Nomoto; Y Ohkubo; C Sekiguchi; S Mutoh; I Yamaguchi; H Aoki
Journal:  Atherosclerosis       Date:  1987-04       Impact factor: 5.162

View more
  5 in total

1.  The polypyrimidine tract binding protein regulates desaturase alternative splicing and PUFA composition.

Authors:  Holly T Reardon; Woo Jung Park; Jimmy Zhang; Peter Lawrence; Kumar S D Kothapalli; J Thomas Brenna
Journal:  J Lipid Res       Date:  2011-10-06       Impact factor: 5.922

2.  Growth hormone enhances arachidonic acid metabolites in a growth hormone transgenic mouse.

Authors:  A M Oberbauer; J B German; J D Murray
Journal:  Lipids       Date:  2011-03-27       Impact factor: 1.880

Review 3.  An eicosanoid-centric view of atherothrombotic risk factors.

Authors:  Scott Gleim; Jeremiah Stitham; Wai Ho Tang; Kathleen A Martin; John Hwa
Journal:  Cell Mol Life Sci       Date:  2012-04-11       Impact factor: 9.261

4.  Expression of an ovine growth hormone transgene in mice increases arachidonic acid in cellular membranes.

Authors:  J D Murray; A M Oberbauer; K R Sharp; J B German
Journal:  Transgenic Res       Date:  1994-07       Impact factor: 2.788

5.  12/15-lipoxygenase-dependent myeloid production of interleukin-12 is essential for resistance to chronic toxoplasmosis.

Authors:  Melissa K Middleton; Alicia M Zukas; Tanya Rubinstein; Michelle Kinder; Emma H Wilson; Peijuan Zhu; Ian A Blair; Christopher A Hunter; Ellen Puré
Journal:  Infect Immun       Date:  2009-10-12       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.